David J. Blanchard

Array ( [id] => 902110 [patent_doc_number] => 07335351 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-26 [patent_title] => 'Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme' [patent_app_type] => utility [patent_app_number] => 10/831075 [patent_app_country] => US [patent_app_date] => 2004-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 41 [patent_no_of_words] => 14994 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/335/07335351.pdf [firstpage_image] =>[orig_patent_app_number] => 10831075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7061042 [patent_doc_number] => 20050003403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Polyvalent protein complex' [patent_app_type] => utility [patent_app_number] => 10/829388 [patent_app_country] => US [patent_app_date] => 2004-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 32446 [patent_no_of_claims] => 116 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20050003403.pdf [firstpage_image] =>[orig_patent_app_number] => 10829388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7202537 [patent_doc_number] => 20050042632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Antibodies having specificity for nucleic acids' [patent_app_type] => utility [patent_app_number] => 10/820622 [patent_app_country] => US [patent_app_date] => 2004-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 29474 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042632.pdf [firstpage_image] =>[orig_patent_app_number] => 10820622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5219748 [patent_doc_number] => 20070161059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'N1,n12-diacetylspermine as tumor marker' [patent_app_type] => utility [patent_app_number] => 10/548658 [patent_app_country] => US [patent_app_date] => 2004-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 11558 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20070161059.pdf [firstpage_image] =>[orig_patent_app_number] => 10548658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7316708 [patent_doc_number] => 20040223970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Antibodies against SLC15A2 and uses thereof' [patent_app_type] => new [patent_app_number] => 10/789090 [patent_app_country] => US [patent_app_date] => 2004-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14959 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20040223970.pdf [firstpage_image] =>[orig_patent_app_number] => 10789090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7258042 [patent_doc_number] => 20040260068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Humanized chicken antibodies' [patent_app_type] => new [patent_app_number] => 10/788625 [patent_app_country] => US [patent_app_date] => 2004-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 24747 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20040260068.pdf [firstpage_image] =>[orig_patent_app_number] => 10788625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7088523 [patent_doc_number] => 20050008635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Humanized antibodies that bind to the antigen bound by antibody NR-LU-13 and their use in pretargeting methods' [patent_app_type] => utility [patent_app_number] => 10/787067 [patent_app_country] => US [patent_app_date] => 2004-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 20486 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20050008635.pdf [firstpage_image] =>[orig_patent_app_number] => 10787067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 221148 [patent_doc_number] => 07608694 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-27 [patent_title] => 'Antibody molecules having specificity for human IL-1β' [patent_app_type] => utility [patent_app_number] => 10/544911 [patent_app_country] => US [patent_app_date] => 2004-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 14 [patent_no_of_words] => 12164 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/608/07608694.pdf [firstpage_image] =>[orig_patent_app_number] => 10544911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851149 [patent_doc_number] => 20060234340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Human heavy chain antibody expression in flamentous fungi' [patent_app_type] => utility [patent_app_number] => 10/544302 [patent_app_country] => US [patent_app_date] => 2004-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11768 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234340.pdf [firstpage_image] =>[orig_patent_app_number] => 10544302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7338102 [patent_doc_number] => 20040132972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Tri-hybrid melanoma antigen' [patent_app_type] => new [patent_app_number] => 10/469217 [patent_app_country] => US [patent_app_date] => 2004-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6899 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132972.pdf [firstpage_image] =>[orig_patent_app_number] => 10469217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6990501 [patent_doc_number] => 20050089538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'CDR grafted type III anti-CEA humanized mouse monoclonal antibodies' [patent_app_type] => utility [patent_app_number] => 10/755382 [patent_app_country] => US [patent_app_date] => 2004-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11178 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20050089538.pdf [firstpage_image] =>[orig_patent_app_number] => 10755382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 21532 [patent_doc_number] => 07799327 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-21 [patent_title] => 'Autoantibodies utilized as carrier agents for pharmaceutical compounds used in cancer treatment' [patent_app_type] => utility [patent_app_number] => 10/745308 [patent_app_country] => US [patent_app_date] => 2003-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3686 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/799/07799327.pdf [firstpage_image] =>[orig_patent_app_number] => 10745308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7307461 [patent_doc_number] => 20040141979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Cancerous disease modifying antibodies' [patent_app_type] => new [patent_app_number] => 10/743451 [patent_app_country] => US [patent_app_date] => 2003-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7060 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20040141979.pdf [firstpage_image] =>[orig_patent_app_number] => 10743451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7593346 [patent_doc_number] => 07651854 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-26 [patent_title] => 'Methods for increasing the proliferation of B cells' [patent_app_type] => utility [patent_app_number] => 10/546868 [patent_app_country] => US [patent_app_date] => 2003-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 7078 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/651/07651854.pdf [firstpage_image] =>[orig_patent_app_number] => 10546868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7264773 [patent_doc_number] => 20040151721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Humanized anti-CCR2 antibodies and methods of use therefor' [patent_app_type] => new [patent_app_number] => 10/733563 [patent_app_country] => US [patent_app_date] => 2003-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 40393 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20040151721.pdf [firstpage_image] =>[orig_patent_app_number] => 10733563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4675652 [patent_doc_number] => 20080213281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Butyrylcholinesterase Variants that Alter the Activity of Chemotherapeutic Agents' [patent_app_type] => utility [patent_app_number] => 10/535441 [patent_app_country] => US [patent_app_date] => 2003-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 25239 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213281.pdf [firstpage_image] =>[orig_patent_app_number] => 10535441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5710014 [patent_doc_number] => 20060051359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Recombinant immunotoxin and use in treating tumors' [patent_app_type] => utility [patent_app_number] => 10/537061 [patent_app_country] => US [patent_app_date] => 2003-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18931 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20060051359.pdf [firstpage_image] =>[orig_patent_app_number] => 10537061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5252780 [patent_doc_number] => 20070134236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Humanized antibodies against monocyte chemotactric proteins' [patent_app_type] => utility [patent_app_number] => 10/536067 [patent_app_country] => US [patent_app_date] => 2003-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 49090 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 46 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20070134236.pdf [firstpage_image] =>[orig_patent_app_number] => 10536067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5842267 [patent_doc_number] => 20060121047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Use of hmgb polypetides for increasing immune responses' [patent_app_type] => utility [patent_app_number] => 10/535267 [patent_app_country] => US [patent_app_date] => 2003-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11354 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121047.pdf [firstpage_image] =>[orig_patent_app_number] => 10535267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7462242 [patent_doc_number] => 20040166115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-26 [patent_title] => 'Use of multi-specific, non-covalent complexes for targeted delivery of therapeutics' [patent_app_type] => new [patent_app_number] => 10/714391 [patent_app_country] => US [patent_app_date] => 2003-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11401 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20040166115.pdf [firstpage_image] =>[orig_patent_app_number] => 10714391 [rel_patent_id] =>[rel_patent_doc_number] =>)